))
Beyond the Trip: Psychedelics and Their Impact on Healthcare
Manage episode 430665141 series 3046075
Contenu fourni par Vynamic. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Vynamic ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
The re-emergence of clinical research into psychedelics as mental health treatment has become a promising development – particularly in light of the current global mental health crisis. However, persistent stigma around psychedelics, regulatory hurdles, and research challenges are a few factors to overcome before psychedelics could be more widely available. In today’s episode, Jen is joined by Vynamic’s Nick Fletcher and Grace Burtonwood to shine light on the opportunities and challenges psychedelics present to the mental health market.
Podcast Tags: healthcare, life sciences, healthcare news, mental health, psychedelics
Source Links:
- WHO Topics: Mental Health
- WHO Fact Sheets: Mental Disorders
- WHO: Global Health Estimates
- Multidisciplinary Association for Psychedelic Studies (MAPS)
- National Institute on Drug Abuse (NIDA)
- Compass Pathways
- BBC – FDA Advisory Committee Vote on MDMA
- FDA Guidance on Clinical Trials with Psychedelic Drugs
- How To Change Your Mind (Michael Pollen)
- European Medicines Agency (EMA)
Panel – Grace Burtonwood, Jen Burke, Nick Fletcher
Research & Production – Everly Petruzzelli, Nick Fletcher
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
194 episodes
Partager
